| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4869143
Max Phase: Preclinical
Molecular Formula: C14H16N2O3
Molecular Weight: 260.29
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1cc2nc3n(c2cc1C)[C@H]1OC[C@@H](O)[C@H]1OC3
Standard InChI: InChI=1S/C14H16N2O3/c1-7-3-9-10(4-8(7)2)16-12(15-9)6-18-13-11(17)5-19-14(13)16/h3-4,11,13-14,17H,5-6H2,1-2H3/t11-,13-,14+/m1/s1
Standard InChI Key: RLTVKYJXJOOFRY-BNOWGMLFSA-N
Associated Targets(Human)
HEp-2 3859 Activities
Associated Targets(non-human)
Respiratory syncytial virus 3434 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 260.29 | Molecular Weight (Monoisotopic): 260.1161 | AlogP: 1.44 | #Rotatable Bonds: 0 |
| Polar Surface Area: 56.51 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.28 | CX Basic pKa: 4.98 | CX LogP: 1.82 | CX LogD: 1.82 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.78 | Np Likeness Score: 0.06 |
References
| 1. Huo X, Hou D, Wang H, He B, Fang J, Meng Y, Liu L, Wei Z, Wang Z, Liu FW.. (2021) Design, synthesis, in vitro and in vivo anti-respiratory syncytial virus (RSV) activity of novel oxizine fused benzimidazole derivatives., 224 [PMID:34256126] [10.1016/j.ejmech.2021.113684] |
Source
Source(1):